Compare ESPR & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESPR | EH |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.7M | 866.0M |
| IPO Year | 2013 | 2019 |
| Metric | ESPR | EH |
|---|---|---|
| Price | $2.65 | $10.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $7.60 | ★ $21.85 |
| AVG Volume (30 Days) | ★ 4.6M | 595.3K |
| Earning Date | 03-10-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $403,135,000.00 | N/A |
| Revenue This Year | $0.69 | $53.34 |
| Revenue Next Year | $10.67 | $75.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 21.31 | N/A |
| 52 Week Low | $0.73 | $9.96 |
| 52 Week High | $4.18 | $23.34 |
| Indicator | ESPR | EH |
|---|---|---|
| Relative Strength Index (RSI) | 40.23 | 33.13 |
| Support Level | $2.37 | N/A |
| Resistance Level | $3.02 | $12.80 |
| Average True Range (ATR) | 0.20 | 0.58 |
| MACD | -0.00 | -0.14 |
| Stochastic Oscillator | 38.52 | 13.87 |
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.